Skip to main content
SpringerLink
Log in

Injizierbare Füllmaterialien

Nebenwirkungen und Management

Injectable fillers

Adverse reactions and their management

  • CME Zertifizierte Fortbildung
  • Published:
Der Hautarzt Aims and scope Submit manuscript

An Erratum to this article was published on 12 September 2013

Zusammenfassung

Injizierbare Füllmaterialien sind eine feste Säule der ästhetischen Medizin. Ihre Anwendung ist im Allgemeinen sicher. Jedoch kann es zu unerwünschten Reaktionen kommen. Diese unerwünschten Reaktionen können akut, subakut und verzögert, d. h. nach Jahren auftreten. Wichtig ist es, diese unerwünschten Reaktionen zu erkennen und auf sie vorbereitet sein, um sie adäquat, d. h. unter Berücksichtigung aller Aspekte wie Art der unerwünschten Reaktion, verwendetes Füllmaterial und ggf. Begleiterkrankungen zu behandeln. Alle unerwünschten Reaktionen sollten an entsprechende Register bzw. die Behörden gemeldet werden. Nur so können wir mehr über diese Reaktionen und ihre Behandlung erfahren.

Abstract

Injectable fillers are one of the corner stones of aesthetic medicine. In general they are safe to use. However, adverse reactions may occur. These reactions may be acute, subacute or delayed, e.g. after decades. It is important to know these reactions and to be prepared so that they can be adequately treated, in view of the clinical symptoms, the injected material and if applicable other diseases/treatments that might trigger these reactions. Last but not least, all reactions should be reported either to specialized registries or regulatory agencies. Only then we are able to learn more about these reactions and their best possible treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Andre P (2004) Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA – Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 18:422–425

    Article  PubMed  CAS  Google Scholar 

  2. Bachmann F, Erdmann R, Hartmann V et al (2011) Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety Study. J Eur Acad Dermatol Venereol 25:902–912

    Article  PubMed  CAS  Google Scholar 

  3. Bachmann F, Erdmann R, Hartmann V et al (2009) The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. Dermatol Surg 35(Suppl 2):1629–1634

    Article  PubMed  CAS  Google Scholar 

  4. Rohrich RJ, Hanke CW, Busso M et al (2011) Facial soft-tissue fillers conference: assessing the state of the science. J Am Acad Dermatol 64:S66–85

    Article  PubMed  Google Scholar 

  5. Rzany B, Becker-Wegerich P, Bachmann F et al (2009) Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use. J Cosmetic Dermatol 8:317–323

    Article  Google Scholar 

  6. Park TH, Seo SW, Kim JK et al (2011) Clinical experience with hyaluronic acid-filler complications. J Plast Reconstr Aest Surg 64:892–896

    Article  Google Scholar 

  7. Bjarnsholt T, Tolker-Nielsen T, Givskov M et al (2009) Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg 35(Suppl 2):1620–1624

    Article  PubMed  CAS  Google Scholar 

  8. Wiest LG, Stolz W, Schroeder JA (2009) Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients. Dermatol Surg 35(Suppl 2):1681–1688

    Article  PubMed  CAS  Google Scholar 

  9. Descamps V, Landry J, Frances C et al (2008) Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases. Dermatology 217:81–84

    Article  PubMed  Google Scholar 

  10. Nast A, Eming S, Fluhr J et al (2012) German S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids). J German Soc Dermatol 10:747–760

    Google Scholar 

  11. Cassuto D, Marangoni O, De Santis G et al (2009) Advanced laser techniques for filler-induced complications. Dermatol Surg 35(Suppl 2):1689–1695

    Article  PubMed  CAS  Google Scholar 

  12. Kim DW, Yoon ES, Ji YH et al (2011) Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. J Plast Reconstr Aest surg 64:1590–1595

    Article  Google Scholar 

  13. Skipr. Tot nu toe 25 klachten over rimpelfiller. http://www.skipr.nl/actueel/id12523-tot-nu-toe-25-klachten-over-rimpelfiller.html (Zugegriffen: 25.10.2012)

Download references

Interessenkonflikt

Der korrespondierende Autor weist für sich und seine Koautoren auf folgende Beziehungen hin: Berthold Rzany ist Referent und Berater der Galderma Laboratorium GmbH und der Merz Pharmaceuticals GmbH. 2012 erfolgte zudem eine Referententätigkeit für Teoxane Laboratoires und Pharm-Allergan GmbH. Von Alexander Nast und Ricardo Erdmann werden keine Interessenskonflikte angegeben.

Author information

Authors and Affiliations

  1. RZANY & HUND, Privatpraxis für Dermatologie und Ästhetische Medizin, Kurfürstendamm 183, 10707, Berlin, Deutschland

    B. Rzany ScM

  2. Division of Evidence Based Medicine (dEBM), Klinik für Dermatologie, Charité - Universitätsmedizin Berlin, Berlin, Deutschland

    F. Bachmann & A. Nast

Authors
  1. B. Rzany ScM
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Bachmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Nast
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Rzany ScM.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rzany, B., Bachmann, F. & Nast, A. Injizierbare Füllmaterialien. Hautarzt 64, 117–127 (2013). https://doi.org/10.1007/s00105-012-2523-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-012-2523-8

Schlüsselwörter

Keywords

Search

Navigation